"Amyloid immunotherapy has consistently shown an increase in brain volume loss – leading to concerns in the media and medical ...

Biogen expects growth of its keenly watched Alzheimer's disease drug, Leqembi, to see a "linear trend" in the United States ...

Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate ...

While we have made progress with FDA approval of two treatments that can slow cognitive decline in early-stage Alzheimer’s ...

Scientists have created a game-changing 'Alzheimer's in a dish' model that allows for faster and more accurate testing of ...

EXCLUSIVE: UCL researchers argue that loss of brain volume may in fact be a sign that the treatments are working.

Alzheimer’s disease remains one of the most pressing challenges in modern medicine, ranking as a leading cause of death ...

A study conducted bà Cattolica in Rome and the Fondazione Policlinico Universitario Agostino Gemelli IRCCS has uncovered a ...

The Cassava Sciences story ended Monday exactly as many knew it would — with the company’s experimental drug for Alzheimer’s ...

New research has established a link between a specific type of body fat and brain proteins that are hallmarks of Alzheimer’s ...

Greeny, A, Nair, A, Sadanandan, P, Satarker, S, Famurewa, AC and Nampoothiri, M (2024) Epigenetic Alterations in Alzheimer's ...